Erschienen in:
06.02.2020 | Meeting Report
Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11–13 2018, Milan, Italy
verfasst von:
Matteo Bellone, Arianna Brevi, Stefania Bruzzì, Michela Consonni, Francesca De Santis, Giulia Di Lullo, Maria Teresa Majorini, Anna Pastò, Alberto Amadori, Marco Bregni, Massimo Di Nicola, Luana Calabrò, Pier Francesco Ferrucci, Enrico Proietti, Mario Paolo Colombo, Vincenzo Russo
Erschienen in:
Cancer Immunology, Immunotherapy
|
Ausgabe 6/2020
Einloggen, um Zugang zu erhalten
Excerpt
The XVI annual meeting of the Italian Network for Tumor Biotherapy (NIBIT) took place in Milan, Italy, on October 11–13, 2018. International leader scientists from academic institutions and pharmaceutical industries presented updates of the new research achievements on cancer bio-immunotherapy. The meeting aimed at building close connections between clinical and pre-clinical research. Many topics were discussed during the meeting, such as (a) Tumor microenvironment; (b) Adoptive cell therapy with CAR-T cells; (c) Commensal microorganisms, metabolism, immune cells and cancer; (d) Cancer vaccines, elicited T cells and their interaction with tumor cells; (e) Novel insights into the biology of anti-tumor T cells; (f) Prospective NIBIT collaborations. A brief summary of the topics discussed in the meeting is reported. …